Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Rap1 organizes lymphocyte front-back polarity via RhoA signaling and talin1" [iScience, Volume 26, Issue 8 (2023) 107292].

iScience·2026
Same author

A scalable high-throughput platform for the discovery of intracellular and extracellular regulators of platelet migration.

Blood advances·2026
Same author

A novel G13-RAPGEF2-RAP1 signaling pathway critical for platelet adhesion and aggregation.

Blood·2026
Same author

The fibrinogen αC region promotes arterial thrombosis in the context of hypofibrinogenemia.

Blood·2026
Same author

RAP1-RHO small GTPase cross-talk mediates integrin-dependent and -independent platelet procoagulant response.

Haematologica·2026
Same author

Platelet-derived integrin- and tetraspanin-enriched tethers exacerbate severe inflammation.

Science (New York, N.Y.)·2026

Related Experiment Video

Updated: Dec 19, 2025

Purification of Platelets from Mouse Blood
05:41

Purification of Platelets from Mouse Blood

Published on: May 7, 2019

23.3K

Novel Mouse Model for Studying Hemostatic Function of Human Platelets.

David S Paul1,2, Wolfgang Bergmeier1,2

  • 1From the Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill (D.S.P., W.B.).

Arteriosclerosis, Thrombosis, and Vascular Biology
|June 5, 2020
PubMed
Summary

A novel humanized mouse model allows testing antiplatelet drugs using human platelets. This model accurately predicts drug efficacy and safety, overcoming limitations of traditional animal studies for thrombosis research.

Keywords:
adoptive transferhemostasismodels, animalsplateletsthrombosis

More Related Videos

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

16.1K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.2K

Related Experiment Videos

Last Updated: Dec 19, 2025

Purification of Platelets from Mouse Blood
05:41

Purification of Platelets from Mouse Blood

Published on: May 7, 2019

23.3K
Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

16.1K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.2K

Area of Science:

  • Hematology
  • Pharmacology
  • Translational Medicine

Background:

  • Platelets are crucial for hemostasis and atherothrombosis.
  • Preclinical models using mice face limitations due to human-mouse platelet differences and drug selectivity.
  • Existing models struggle to accurately predict antiplatelet drug efficacy and safety in humans.

Purpose of the Study:

  • To develop a novel mouse model for evaluating antiplatelet drugs using human platelets.
  • To overcome species-specific limitations in preclinical antiplatelet drug testing.
  • To assess the hemostatic function of human platelets in a xenogeneic model.

Main Methods:

  • Developed a protocol for adoptive transfer of human platelets into thrombocytopenic immunodeficient mice.
  • Utilized intravital spinning disk confocal microscopy to visualize hemostatic plug formation after laser injury.
  • Administered antiplatelet agents (Aspirin, Ticagrelor, PAR1 inhibitor) to assess their effects on hemostasis.

Main Results:

  • Achieved integrin αIIbβ3-dependent hemostatic plug formation within 30 seconds in humanized mice.
  • Dual antiplatelet therapy (Aspirin+Ticagrelor) and PAR1 inhibition mildly prolonged bleeding time and reduced platelet adhesion.
  • Combined PAR1 inhibition with dual antiplatelet therapy significantly prolonged bleeding time, mirroring clinical trial findings.

Conclusions:

  • The developed humanized platelet mouse model offers a robust platform for antiplatelet drug testing.
  • This model can predict the safety and efficacy of novel antiplatelet therapies.
  • It enables characterization of hemostatic function for various platelet types, including synthetic and patient-derived platelets.